Aqneursa

Active Ingredient(s): Levacetylleucine
FDA Approved: * September 24, 2024
Pharm Company: * INTRABIO
Category: Genetic Disorders
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Aqneursa 1000 mg Oral Granule, for Suspension
NDC: 83853-101
Labeler:
Intrabio Inc